Evidence map›Paper›PMID 28455214›Full record

ReviewBone2018

Conserved signaling pathways underlying heterotopic ossification.

Chen Kan, Lijun Chen, Yangyang Hu, Na Ding, Haimei Lu, Yuyun Li, John A Kessler, Lixin Kan

Erratum issuedAbstract readReview
In one paragraph

Review in Bone, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
2.7field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 46 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Fibroblasts in heterotopic ossification: mechanisms and therapeutic targets.International journal of biological sciences · 2025
    Review
  8. Article
  9. Review
  10. Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. Review
  16. Article
  17. Review
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

Chen KanSchool of Basic Medical Sciences, Anhui Medical University, Hefei 230032, China.
Lijun ChenSchool of Basic Medical Sciences, Anhui Medical University, Hefei 230032, China.
Yangyang HuSchool of Basic Medical Sciences, Anhui Medical University, Hefei 230032, China.
Na DingSchool of Basic Medical Sciences, Anhui Medical University, Hefei 230032, China.
Haimei LuSchool of Basic Medical Sciences, Anhui Medical University, Hefei 230032, China.
Yuyun LiDepartment of Medical Laboratory Science, Bengbu Medical College, Bengbu 233030, China.
John A KesslerDepartment of Neurology, Feinberg School of Medicine, Northwestern University, Chicago, IL 60611, USA.
Lixin KanSchool of Basic Medical Sciences, Anhui Medical University, Hefei 230032, China; Department of Medical Laboratory Science, Bengbu Medical College, Bengbu 233030, China; Department of Neurology, Feinberg School of Medicine, Northwestern University, Chicago, IL 60611, USA. Electronic address: l-kan@northwestern.edu.
Anhui Medical University · CNBengbu Medical College · CNNorthwestern University · US

Funding

Mechanisms Underlying Heterotopic OssificationR01AR066539 · NIAMS · NORTHWESTERN UNIVERSITY AT CHICAGO · PI KESSLER, JOHN A · 2015 to 2019
$2.0M
NIAMS NIH HHS R01 AR066539
6 · The paper itself

Abstract

Heterotopic ossification (HO), a serious disorder of extra-skeletal bone formation, occurs as a common complication of trauma or in rare genetic disorders. Many conserved signaling pathways have been implicated in HO; however, the exact underlying molecular mechanisms for many forms of HO are still unclear. The emerging picture is that dysregulation of bone morphogenetic protein (BMP) signaling plays a central role in the process, but that other conserved signaling pathways, such as Hedgehog (HH), Wnt/β-catenin and Fibroblast growth factors (FGF), are also involved, either through cross-talk with BMP signaling or through other independent mechanisms. Deep understanding of the conserved signaling pathways is necessary for the effective prevention and treatment of HO. In this review, we update and integrate recent progress in this area. Hopefully, our discussion will point to novel promising, druggable loci for further translational research and successful clinical applications.

Indexed as

AnimalsBone Morphogenetic ProteinsFibroblast Growth FactorsHumansMyositis OssificansOssification, HeterotopicSignal TransductionTransforming Growth Factor betaBone Morphogenetic ProteinsFibroblast Growth FactorsTransforming Growth Factor betaBone morphogenetic protein (BMP)Conserved signaling pathwaysFibroblast growth factor (FGF)Fibrodysplasia ossificans progressiva (FOP)Hedgehog (HH)Heterotopic ossification (HO)Transforming growth factor β (TGF-β)Wnt/β-catenin

Identifiers

PMID28455214
PMCPMC5801212
OpenAlexW2609113069

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.